FDA
-
US Approves Groundbreaking Alzheimer's Disease Drug Lecanemab Amid Multiple Deaths Reported
The FDA approved the usage of Leqembi (Lecanemab) as the first Alzheimer’s treatment despite of reported deaths linked to the drug.
Latest Research Articles
-
Known Dog Food Product Kills 70 Dogs, Company Expands Voluntary Recall
-
‘Vaginal Rejuvenation’ Devices Have Serious Side Effects, Unproven Claims: FDA
-
Smallpox Drug Gets Approved By FDA As Measure Against Bioterrorism
-
Excessive Sweating Treatment Qbrexza Has Been Approved By The FDA
-
FDA Determines Source Of Romaine Lettuce E. Coli Outbreak
-
First Marijuana Drug Gets Approved By The FDA
-
FDA Warning: Do Not Use So-Called Sunscreen Pills
-
First FDA-Approved Drug That Prevents Chronic Migraine Costs $6,900 A Year
-
1 in 3 New Drugs Approved by the FDA Had Some Unexpected Complications
-
Newly Approved Drug for ALS 'Radicava' Costs Over $145,000 a Year
-
FDA Green-Lights Selling of 23andMe's First-Ever Home Genetic Testing Kit
-
Caffeine Boost? Try the World's Strongest Coffee 'Black Insomnia' That's 10 Times Stronger Than Red Bull